EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges

Sebastian Torke iD, Sarah Dybowski iD, Martin S Weber iD

Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-16

DOI: 10.2147/dddt.s568214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Sebastian Torke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center, Charité-Medical Center Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Autoimmune Diseases, Protein Kinase Inhibitors, Autoimmunity. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseAutoimmune DiseasesProtein Kinase InhibitorsAutoimmunityHumansAnimals

Stichwörter der Autor:innen

BTK inhibitionPROTACsautoimmune diseasesmolecular glue degradersmultiple sclerosisrheumatoid arthritissystemic lupus erythematosus

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsBTK protein, human

Autor:innen und Institutionen

  • Experimental and Clinical Research Center, Charité-Medical Center Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Translational Neuroinflammation and Automated Microscopy TNM, Göttingen, Germany.

ORCID-Profile: Sebastian Torke, Sarah Dybowski, Martin S Weber

Zitieren

APA

Torke, S., Dybowski, S., & Weber, M. S. (2026). Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s568214

Vancouver

Torke S, Dybowski S, Weber MS. Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s568214

BibTeX
@article{Torke2026,
  author = {Torke, Sebastian and Dybowski, Sarah and Weber, Martin S},
  title = {Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--16},
  doi = {10.2147/dddt.s568214}
}
Kostenlos starten →